199f4f25-f7d5-4884-9672-1da118f0ac4e

Something® for a Liver Reset

The first-ever nutraceutical to fight Fatty Liver

$95.00
$95.00

A superior blend of clinically backed ingredients, designed to fight the root cause of 70% of disease: fatty liver.

A person wearing a white blazer and a necklace, on a neutral background.

Clinical studies indicate you should stay in the program for 6-12 months to experience the full transformation.

Teresa Fonseca - Medicine Practitioner

1

No commitment. Cancel anytime

90 days risk free guarantee

Do you have a fatty liver?

There's a 60 to 95% chance you do, if 2 or more of these risk factors apply:

1 or more sugary drinks per day

14+ glasses of wine / beers per week

Belly fat, overweight or obese

Junk food 3 or more times per week

High cholesterol or triglycerides

Heart disease or type 2 diabetes

Checked 2 or more, but have no symptoms, nor have you been diagnosed with fatty liver by your physician? Here's why: Fatty liver disease is silent and is usually detected by chance. Today, over 100 million Americans are living with it most without knowing.

Illustration of a diseased liver with a close-up of cell structure.

Don’t let damage
become irreversible

HEALTHY LIVER

Realistic 3D rendering of a human liver.

Reset brings the organ that runs your body back to normal, restoring your health: less fatigue, less weight gain and inflammation, improved heart biomarkers and more.

NO DAMAGE

FATTY LIVER

Human liver with a yellowish surface due to steatosis (fat accumulation).

A fatty liver means a disrupted liver, which means a disrupted body. The latest research shows that it is the root cause of heart disease, dementia, diabetes, and cirrhosis.

REVERSIBLE DAMAGE

NASH

Detailed close-up of a human liver.

30% of people with fatty liver develop NASH in as little as 3 years. Fat inflames and kills liver cells. Dead cells are replaced by scar tissue (fibrosis) that never recovers.

IREVERSIBLE DAMAGE

CIRRHOSIS

A realistic 3D rendering of a human liver model.

If inflammation continues, scar tissue stiffens the liver, deeply disrupting its function. This highly increases the risk of liver failure and the need for a transplant.

IREVERSIBLE DAMAGE

Don’t let damage
become irreversible

HEALTHY LIVER

Realistic 3D rendering of a human liver.

Reset brings the organ that runs your body back to normal, restoring your health: less fatigue, less weight gain and inflammation, improved heart biomarkers and more.

NO DAMAGE

FATTY LIVER

Human liver with a yellowish surface due to steatosis (fat accumulation).

A fatty liver means a disrupted liver, which means a disrupted body. The latest research shows that it is the root cause of heart disease, dementia, diabetes, and cirrhosis.

REVERSIBLE DAMAGE

NASH

Detailed close-up of a human liver.

30% of people with fatty liver develop NASH in as little as 3 years. Fat inflames and kills liver cells. Dead cells are replaced by scar tissue (fibrosis) that never recovers.

IRREVERSIBLE DAMAGE

CIRRHOSIS

A realistic 3D rendering of a human liver model.

If inflammation continues, scar tissue stiffens the liver, deeply disrupting its function. This highly increases the risk of liver failure and the need for a transplant.

IRREVERSIBLE DAMAGE

Fight Fatty Liver

in 6 to 12 months

Timeline showing fat reduction percentages over months 1, 3, and 6-12.
Close-up of yellow capsules with textured surfaces.

Who can benefit from Liver Reset?

Something® for a liver reset arrives at a critical time: the latest research shows that, if no action is taken, half the global population will have fatty liver disease by 2035.

Yellow capsules with cracked texture on a white background.

Values refer to the 6-12 month program.

Biomarker improvements refer to initial values and progress only up to optimal levels. For example, optimal LDL cholesterol is 50-70 mg/dL. Those already in this range won’t see changes, but someone with 100 mg/dL could see a 42 mg/dL reduction, stabilizing at an optimal 58 mg/dL.

Fingers holding two yellow capsules against a black background.

Such power in one capsule?

The latest technology plus superior ingredients:

Phytosome™ technology enhances nutrient absorption by up to 30 times compared to traditional methods, delivering more benefits with fewer capsules.

LIVER RESET CONTAINS

5 clinically backed ingredients for a Multi-Targeted Approach to Liver Fat

Close-up of a green bergamot with a slice showing its interior.

600mg Vazguard® Bergamot

The most effective plant to remove fat from liver cells.

A close-up image of bright yellow turmeric powder.

210mg Meriva® Curcumin

The most powerful anti-inflammatory and antioxidant found in nature

Close-up of a vibrant purple thistle flower in full bloom.

100mg Siliphos® Silybin

Clinically proven to reduce mortality risk in patients with excess liver fat.

Close-up view of artichoke leaves, showcasing textures and green hues.

60mg Artichoke leaf extract

Clinically proven to reduce liver fat in 82% of patients.

A close-up of white powder with a depression in the center.

20mg Vitamin E

The most crucial vitamin to neutralize fatty liver damage.

Woman in white coat next to liver health product and capsules.

Easy to follow

Daily recommendation

Take 2 capsules before your first meal for 25 consecutive days. Rest for 5 days, then repeat.

1

Treatment length

Fighting fatty liver requires a commitment of 6 to 12 months, but transformative benefits can be felt as early as the first month of treatment (e.g. reduced tiredness). Consistency is key.

2

What to expect

Significant decrease in liver fat, accompanied by a reduction of symptoms associated with fatty liver (e.g. less fatigue, reduced weight gain, less restless nights). We recommend pairing this program with a whole-food diet and at least 150 minutes of exercise per week for maximum results.

3

Your Questions Answered

References

1. https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-fatty-liver-disease-nafld/#:~:text=About%20100%20million%20individuals%20in,over%20the%20past%2020%20years

2. Minhas AMK, Jain V, Maqsood MH, et al. Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey. Curr Probl Cardiol. 2022;47(12):101333.

3. Loomba R, Wong R, Fraysse J, et al. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Aliment Pharmacol Ther. 2020;51(11):1149-1159.


4. Shang Y, Widman L, Hagström H. Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study. Neurology. 2022;99(6):e574-e582.


5. Le MH, Yeo YH, Zou B, et al. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach. Clin Mol Hepatol. 2022;28(4):841-850.


6. Ferro Y, Montalcini T, Mazza E, et al. Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years. Front Endocrinol (Lausanne). 2020;11:494. Published 2020 Aug 11.


7. Rondanelli M, Giacosa A, Opizzi A, et al. Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial. Int J Food Sci Nutr. 2013;64(1):7-15.


8. Rangboo V, Noroozi M, Zavoshy R, Rezadoost SA, Mohammadpoorasl A. The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis. Int J Hepatol. 2016;2016:4030476


9. Cai Y, Xing G, Shen T, Zhang S, Rao J, Shi R. Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial. Lipids Health Dis. 2017 Dec


10. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res.


11. Riva A, Petrangolini G, Allegrini P, Perna S, Giacosa A, Peroni G, Faliva MA, Naso M, Rondanelli M. Artichoke and Bergamot Phytosome Alliance: A Randomized Double Blind Clinical Trial in Mild Hypercholesterolemia. Nutrients. 2021 Dec 27;14(1):108.


12. He Y, Chen X, Li Y, et al. Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial. Am J Clin Nutr. 2024;120(1):66-79


YOUR BAG: 0
{ item.product_id }

Item out of stock in your country!
  • { option.name }: { option.value } | 
{ item.selling_plan_allocation.selling_plan.name }

You don't have any items in your shopping bag.

Your location is set
to United States

Shop in EUR €
Get shipping options for United States

Change country